Comparison of Biodentine and Formocresol in Deciduous Teeth

Introduction: Pulpotomy is a widely used procedure in pediatric dentistry to treat pulp inflammation in the primary dentition. This procedure involves amputation of the inflamed coronal pulp and treatment of the remaining root pulp tissue with the aim of preserving its vitality. However, due to the risks associated with the use of formocresol, the need has arisen to explore safer and more effective alternatives. In this context, the investigation compared the efficacy and safety of Biodentine and formocresol in the treatment of pulp lesions in deciduous teeth. A systematic search of the literature published in the last ten years was carried out in recognized databases such as Scielo, Scopus, Cochrane Library, Google Scholar and PubMed. The selection of studies considered those that evaluated the clinical application, success rate and possible adverse effects of both materials in pulp treatment of primary teeth. The results showed that Biodentine offered better preservation of pulp vitality and a lower incidence of adverse effects compared to formocresol. In addition, the studies reviewed highlighted the biocompatibility and regenerative properties of Biodentine, in contrast to the potential risks associated with the use of formocresol, such as its toxicity and possible carcinogenic effect. It was concluded that Biodentine represents a safer and more effective alternative to formocresol in the treatment of pulpal lesions in deciduous teeth. Its use as the material of choice in pulpotomies would be justified by its superiority in terms of biocompatibility and lower risk of adverse effects